Find an MSK Doctor or Cancer Specialist
Memorial Sloan Kettering surgeon Eugene Pietzak

Eugene Pietzak, MD

Urologic Surgeon

My Role at MSK

Areas of Expertise

Conditions I Treat

  • Bladder cancer
  • Urothelial carcinoma (transitional cell carcinoma)
  • Prostate cancer and conditions

My Specialties

  • Robotic Surgery
  • Urinary reconstruction
  • Open Surgery
View all
Dr. Pietzak's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top
English
Share

About Me

What I Do at MSK
  • Assistant Attending Surgeon
Get To Know Me

I am a board-certified urologic surgeon who specializes in the surgical treatment of bladder cancer, prostate cancer, upper urothelial cancer (cancers that arise in the renal pelvis and ureters), and other cancers of the genitourinary system. I have expertise in a wide array of surgical techniques, including minimally invasive and robotic surgery.

I see patients at the Sidney Kimmel Center for Prostate and Urologic Cancers in Manhattan and MSK Commack on Long Island.

This provider is part of a team that was ranked #1 in the nation for Urology Cancer Care this year by U.S. News & World Report.
Read more

I am committed to achieving cures while preserving quality of life through careful surgical planning and meticulous surgical technique. Whenever possible, I use nerve-sparing and function-sparing techniques to help maintain urinary and sexual function. For men with prostate cancer that requires treatment, I primarily perform robotic-assisted radical prostatectomy. For men and women with bladder cancer who require an operation to remove the bladder (radical cystectomy), I can provide expertise in advanced urinary reconstructive techniques, such as continent neobladder diversion that can re-create the natural urination pathway after bladder removal.

Because the treatment of cancers of the genitourinary system is complex, I work closely with colleagues in medical oncology, radiation oncology, radiology, and pathology to individualize each patient’s treatment approach based on their unique circumstance. I understand that a cancer diagnosis requires people to make many important and oftentimes, difficult decisions. I work with each of my patients and their families to provide as much information as possible regarding all options available to them. By using a patient-centered approach that takes into account individual preferences, I can provide the best possible outcome and quality of life following treatment for all my patients.

In addition to my surgical expertise, I am a surgeon-scientist involved in clinical trials and translational research working towards the development of new treatments for people with bladder cancer, prostate cancer, and upper tract urothelial cancer. We have a large research program focused on identifying ways to personalize and improve treatment options for people with bladder cancer. Our research has led to the development of several clinical trials available at MSK of new treatment approaches for people with bladder cancer so those participating in these trials may receive cutting-edge therapies before they are accessible nationally. The ultimate goal of our research efforts is to provide a better chance of cure and improved quality of life for our patients compared to currently available standard therapies.

My Role at MSK

A urologic surgeon is a doctor with special training in surgery on the genitourinary (jeh-nih-toh-YOOR-ih-nayr-ee) (GU) system. This includes the bladder, kidney, penis, prostate, and testicles.

Areas of Expertise

Conditions I Treat

  • Bladder cancer
  • Urothelial carcinoma (transitional cell carcinoma)
  • Prostate cancer and conditions

My Specialties

  • Robotic Surgery
  • Urinary reconstruction
  • Open Surgery
  • Nerve-sparing surgery
Education & Honors

Education

  • MD, Stony Brook University Medical School

Residencies

  • Urology - Hospital of the University of Pennsylvania

Awards and Honors

  • Castle Connolly: America’s Top Doctor (2024)
  • Top Doctors New York Metro Area, Castle Connolly (2023)
  • Castle Connolly: America's Top Doctors (2023)
  • Alpha Omega Alpha
  • National Cancer Institute’s K12 Paul Calabresi Career Development Award for Clinical Oncology
  • Society of Urologic Oncology/ American Urologic Association Research Scholar Award
  • MSKCC Specialized Program of Research Excellence (SPORE) Career Enhancement Award in Bladder Cancer
  • Bladder Cancer Advocacy Network (BCAN) Young Investigator Award

Fellowships

  • Urologic Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

  • Urology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (MTA and NYC retirees only)

In Network Coverage Type
PPO

Anthem BCBS and other BCBS licensee plans

In Network Coverage Type
PPO, POS, EPO, HMO

See updates

Anthem BCBS Health Plus

In Network Coverage Type
HMO

See updates

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

See updates

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

See updates

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage (Medicare Choice PPO Network and VIP Prime Network Only)

In Network Coverage Type
PPO, HMO

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

See updates

Fidelis

In Network Coverage Type
HMO, EPO

Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

See updates

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

See updates

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

See updates

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

See updates

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9068— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.

Contact and Location

Dr. Pietzak sees patients at two locations.

Office Phone
Location
New York, NY
Commack, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
650 Commack Road Commack NY 11725
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Urology Service doctors

Clinical Trials

Read more
Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.

Male Neobladder.

Neoadjuvant Treatment of High-Risk, Clinically Localized Prostate Cancer Prior to Radical Prostatectomy.

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets. Pietzak EJ, Bagrodia A, Cha EK, Drill EN, Iyer G, Isharwal S, Ostrovnaya I, Baez P, Li Q, Berger MF, Zehir A, Schultz N, Rosenberg JE, Bajorin DF, Dalbagni G, Al-Ahmadie H, Solit DB, Bochner BH. Eur Urol. 2017 Jun 2.

Publications on PubMed

Visit PubMed for a full listing of Dr. Pietzak’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Eugene Pietzak discloses the following relationships and financial interests:

  • CG Oncology, Inc.
    Professional Services and Activities
  • Janssen Global Services, LLC
    Professional Services and Activities
  • Merck & Co Inc.
    Professional Services and Activities
  • QED Therapeutics, Inc.
    Professional Services and Activities
  • UroGen Pharma, Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: